A carregar...
Effects of CDK4/6 Inhibition in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Cells with Acquired Resistance to Paclitaxel
Among patients with hormone receptor (HR)-positive breast cancer, those with residual disease after neoadjuvant chemotherapy have a higher risk of relapse and poorer survival than those with a complete response. Previous studies have revealed a correlation between activation of cell cycle-regulating...
Na minha lista:
| Publicado no: | J Cancer |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Ivyspring International Publisher
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4910587/ https://ncbi.nlm.nih.gov/pubmed/27313785 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.14441 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|